Showing 721-730 of 755 results for "".
- Phase I Trial of Nivolumab Shows Long-Term Efficacy Against Melanomahttps://practicaldermatology.com/news/20140313-phase_i_trial_of_nivolumab_shows_long-term_efficacy_against_melanoma/2459318/A recent study by researchers at Dana-Farber Cancer Institute, Johns Hopkins University, Yale University, and allied institutions, published online in the Journal of Clinical Oncology, provides the longest-term look so far at how melanoma patients have fared since receiving the drug, nivolumab (Bri…
- Indoor Tanning Among High Schoolers Linked to Other Risky Behaviorhttps://practicaldermatology.com/news/20140227-indoor_tanning_among_high_schoolers_linked_to_other_risky_behavior/2459329/A national survey of high school students found that indoor tanning is a common practice, particularly among female, older and non-Hispanic white students, and is associated with several other risky health-related behaviors, according to a study by Gery P. Guy Jr., PhD, MPH of the Centers for Disea…
- Steroids Found to be Widely Prescribed by Dermatologists for Psoriasis Managementhttps://practicaldermatology.com/news/20140220-steroids_found_to_be_widely_prescribed_by_dermatologists_for_psoriasis_management/2459337/When it comes to psoriasis management guidelines, use of systemic corticosteroids are discouraged, but according to a new study from Wake Forest Baptist Medical Center, they are widely prescribed by dermatologists. Researchers at The Center for Dermatology Research at Wake Forest Baptist assessed h…
- Study to Convert Adult Human Cells to Hair-Follicle-Generating Stem Cells has Implications for Hair Regenerationhttps://practicaldermatology.com/news/20140129-study_to_convert_adult_human_cells_to_hair-follicle-generating_stem_cells_has_implications_for_hair_regeneration/2459356/Xiaowei “George” Xu, MD, PhD, associate professor of Pathology and Laboratory Medicine and Dermatology at the Perelman School of Medicine, University of Pennsylvania, and colleagues published in Nature Communications a method for converting adult cells into epithelial stem cel…
- Injectable Methotrexate Product Now Availablehttps://practicaldermatology.com/news/20140117-injectable_methotrexate_product_now_available/2459369/For patients who do not tolerate oral methotrexate for psoriasis, a new recently approved injectable methotrexate product is now available from Antares Pharma. Approved in October 2013 for the subcutaneous methotrexate product for once weekly self-administration, Otrexup is indicated for use in adu…
- Theradome Laser Helmet Launches for At-home Treatment of Hair Losshttps://practicaldermatology.com/news/20131219-theradome_laser_helmet_launches_for_at-home_treatment_of_hair_loss/2459389/Theradome Laser Helmet LH80 PRO, the first FDA and over-the-counter cleared, wearable laser hair restoration treatment, is now available. Developed for in-home use and designed for patients suffering from the effects of thinning hair and Androgenetic Alopecia, Theradome Laser Helmet LH80 PRO is a c…
- Provectus Announces Name Change to Provectus Biopharmaceuticalshttps://practicaldermatology.com/news/20131218-provectus_announces_name_change_to_provectus_biopharmaceuticals/2459391/Provectus Pharmaceuticals, Inc. a development-stage oncology and dermatology biopharmaceutical company, announced that shareholders voted to change the company's name to Provectus Biopharmaceuticals, Inc. and reincorporate in Delaware effective promptly upon regulatory filings…
- NIH Awards Icahn School of Medicine at Mount Sinai $2.7 Million for Eczema Researchhttps://practicaldermatology.com/news/20131126-nih_awards_icahn_school_of_medicine_at_mount_sinai_27_million_for_eczema_research/2459404/The National Institutes of Health has awarded a research team at the Icahn School of Medicine at Mount Sinai $2.7 million to study systemic treatments for patients with moderate to severe atopic dermatitis (AD). The team will investigate the efficacy of a new intravenous medi…
- Antares Pharma Enters into Promotion and Marketing Agreement with LEO Pharma for Otrexuphttps://practicaldermatology.com/news/20131118-antares_pharma_enters_into_promotion_and_marketing_agreement_with_leo_pharma_for_otrexup/2459413/Antares Pharma, Inc. announced an exclusive agreement with LEO Pharma for the promotion and marketing of Otrexup (methotrexate) to dermatologists for symptomatic control of severe recalcitrant psoriasis in adults. Under the terms of the agreement, Antares may receive up to a total of $20 million in…
- Robert Ryan of Scioderm Appointed Member of DebRA Boardhttps://practicaldermatology.com/news/20131021-robert_ryan_of_scioderm_appointed_member_of_debra_board/2459434/Scioderm, Inc.'s co-founder and CEO Robert Ryan, PhD was appointed to the board of directors of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA). DebRA is the only national non-profit group dedicated to funding research and providing services and programs for those with …